Helius Medical Technologies Inc Class A
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -61.8% | -23.8% | +0.0% | +0.0% | -25.0% | -33.3% | +12.5% | +7,266.7% | – | – | – | – | |
| – | -0.5% | +0.0% | -8.7% | +262.6% | -67.7% | +45.3% | -34.2% | +15.6% | +1,537.6% | -98.8% | -30.0% | – | |
| – | -1,300.0% | – | – | – | – | -171.2% | – | +46.7% | -390.0% | – | -457.6% | – | |
| – | -50.0% | +66.7% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | -50.0% | +66.7% | – | – | – | – | – | – | -40.5% | – | +0.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -33.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +36.7% | +135.2% | +285.5% | -102.6% | -100.0% | – | +117.2% | +4,940.1% | -87.5% | -107.3% | – | – | |
| – | – | – | – | -206.2% | – | – | +23,561.9% | +2,274.2% | -199.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.